FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Dilip Davda has given "Apply" recommendation to Unihealth Consultancy IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 1 | 0 | 0 | 0 | 0 |
% | 100.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Dilip Davda | Apply |
[Dilip Davda] The company has healthcare services/product distribution centres in India and the African continent. Considering the business tie-ups between India and Africa on healthcare, this company is poised for bright prospects ahead. FY23 financial performance hints at the opportunities lying ahead. Investors may park funds for short to long-term rewards. Read detail review...
Unihealth Consultancy Limited peer comparison with similar listed entities. (Consolidated) (As on March 31, 2023)
Company Name | EPS (Rs) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | |
---|---|---|---|---|---|
EPS Basic | EPS Diluted | ||||
Unihealth Consultancy Limited | 6.94 | 6.94 | 27.91 | ||
KMC Speciality Hospitals (India) Ltd | 1.64 | 1.64 | 6.96 | 44.88 | 23.51 |
Notes:
Unihealth Consultancy IPO Reviews, analysis and views by popular members. Read Unihealth Consultancy Limited IPO reviews by retail investors to find recommended ipo to buy.
Post Recommendation Manage Your IPO Reviews
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 0 | 0 | 1 | 0 |
% | 0.00 | 0.00 | 100.00 | 0.00 |
Member | Review |
---|---|
Mr G |
Neutral good issue but on a very high valuation so one may apply as the sector is good and they are having there presence in abroad as well September 4, 2023 2:56:23 PM |
Post Recommendation Manage Recommendations
Note:
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|